2-(3-(4-(1,2-benzoxazol-3-yl)piperazin-1-yl)propyl)-1H-isoindole-1,3(2H)-dione | 1365035-89-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 2-(3-(4-(1,2-benzoxazol-3-yl)piperazin-1-yl)propyl)-1H-isoindole-1,3(2H)-dione
• 英文别名: 2-[3-[4-(1,2-Benzoxazol-3-yl)piperazin-1-yl]propyl]isoindole-1,3-dione；2-[3-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]propyl]isoindole-1,3-dione
• CAS: 1365035-89-7
• 化学式: C₂₂H₂₂N₄O₃
• 分子量: 390.442
• InChiKey: XAUPSAKJMHBNSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  69.9
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-(3-(4-(1,2-benzoxazol-3-yl)piperazin-1-yl)propyl)-1H-isoindole-1,3(2H)-dione 在 水 、 三乙胺 、 甲胺 作用下， 以 二氯甲烷 为溶剂， 反应 75.0h， 生成 N-(3-(4-(benzo[d]isoxazol-3-yl)piperazin-1-yl)propyl)-3-methylbenzenesulfonamide
  参考文献：
  名称：

  Novel Arylsulfonamide Derivatives with 5-HT₆/5-HT₇ Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia

  摘要：

  In order to target behavioral and psychological symptoms of dementia (BPSD), we used molecular modeling-assisted design to obtain novel multifunctional arylsulfonamide derivatives that potently antagonize 5-HT6/7/2A and D-2 receptors, without interacting with M-1 receptors and hERG channels. In vitro studies confirmed their antagonism of 5-HT7/2A and D-2 receptors and weak interactions with key antitargets (M1R and hERG) associated with side effects. Marked 5-HT6 receptor affinities were also observed, notably for 6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole derivatives connected by a 3-4 unit alkyl linker with mono- or bicyclic, lipophilic arylsulfonamide moieties. N-[4-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]butyl]benzothiophene-2-sulfonamide (72) was characterized in vitro on 14 targets and antitargets. It displayed dual blockade of 5-HT6 and D-2 receptors and negligible interactions at hERG and M-1 receptors. Unlike reference antipsychotics, 72 displayed marked antipsychotic and antidepressant activity in rats after oral administration, in the absence of cognitive or motor impairment. This profile is particularly attractive when targeting a fragile, elderly BPSD patient population.

  DOI：

  10.1021/jm401895u
• 作为产物：
  描述：

  N-(3-溴丙基)苯二胺 、 3-哌嗪-1,2-苯异唑 在 potassium carbonate 、 potassium iodide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 48.0h， 生成 2-(3-(4-(1,2-benzoxazol-3-yl)piperazin-1-yl)propyl)-1H-isoindole-1,3(2H)-dione
  参考文献：
  名称：

  Novel Arylsulfonamide Derivatives with 5-HT₆/5-HT₇ Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia

  摘要：

  In order to target behavioral and psychological symptoms of dementia (BPSD), we used molecular modeling-assisted design to obtain novel multifunctional arylsulfonamide derivatives that potently antagonize 5-HT6/7/2A and D-2 receptors, without interacting with M-1 receptors and hERG channels. In vitro studies confirmed their antagonism of 5-HT7/2A and D-2 receptors and weak interactions with key antitargets (M1R and hERG) associated with side effects. Marked 5-HT6 receptor affinities were also observed, notably for 6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole derivatives connected by a 3-4 unit alkyl linker with mono- or bicyclic, lipophilic arylsulfonamide moieties. N-[4-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]butyl]benzothiophene-2-sulfonamide (72) was characterized in vitro on 14 targets and antitargets. It displayed dual blockade of 5-HT6 and D-2 receptors and negligible interactions at hERG and M-1 receptors. Unlike reference antipsychotics, 72 displayed marked antipsychotic and antidepressant activity in rats after oral administration, in the absence of cognitive or motor impairment. This profile is particularly attractive when targeting a fragile, elderly BPSD patient population.

  DOI：

  10.1021/jm401895u

文献信息

• ARYLOSULFONAMIDES FOR THE TREATMENT OF CNS DISEASES
  申请人：Kolaczkowski Marcin

  公开号：US20130172365A1

  公开（公告）日：2013-07-04

  Arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of disorders of the central nervous system.

  化学式（I）的芳基磺胺衍生物及其药用盐。这些化合物可能对中枢神经系统疾病的治疗和/或预防有用。
• US8822517B2
  申请人：——

  公开号：US8822517B2

  公开（公告）日：2014-09-02
• US9120767B2
  申请人：——

  公开号：US9120767B2

  公开（公告）日：2015-09-01